Selected research
Industry Research
Human Rabies Vaccine (Vero Cell) Industry Research Report 2026
Market perspective
The global Human Rabies Vaccine (Vero Cell) market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Human Rabies Vaccine (Vero Cell) is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Human Rabies Vaccine (Vero Cell) is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Human Rabies Vaccine (Vero Cell) is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Human Rabies Vaccine (Vero Cell) include Changchun Zhuoyi Biology, Ningbo Rong'an, Liaoning Chengda, Jilin Huikang Biopharmaceutical Co., Ltd., Hualan Bio-vaccine, Guangzhou Nuocheng, Dalian Yali Peak, Chengdu Kanghua Biology and Serum Institute of India Pvt., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Human Rabies Vaccine (Vero Cell) market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Human Rabies Vaccine (Vero Cell) Market by Company
Changchun Zhuoyi Biology
Ningbo Rong'an
Liaoning Chengda
Jilin Huikang Biopharmaceutical Co., Ltd.
Hualan Bio-vaccine
Guangzhou Nuocheng
Dalian Yali Peak
Chengdu Kanghua Biology
Serum Institute of India Pvt.
Sanofi Pasteur SA
Bharat Biotech
Bavarian Nordic
Human Rabies Vaccine (Vero Cell) Segment by Type
0.5ml
1ml
Human Rabies Vaccine (Vero Cell) Segment by Application
Hospital
Clinic
Human Rabies Vaccine (Vero Cell) Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Rabies Vaccine (Vero Cell) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Human Rabies Vaccine (Vero Cell) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Rabies Vaccine (Vero Cell).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Human Rabies Vaccine (Vero Cell) manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Human Rabies Vaccine (Vero Cell) by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Human Rabies Vaccine (Vero Cell) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 0.5ml
- 1ml
Applications
- Hospital
- Clinic
Companies covered
- Changchun Zhuoyi Biology
- Ningbo Rong'an
- Liaoning Chengda
- Jilin Huikang Biopharmaceutical Co., Ltd.
- Hualan Bio-vaccine
- Guangzhou Nuocheng
- Dalian Yali Peak
- Chengdu Kanghua Biology
- Serum Institute of India Pvt.
- Sanofi Pasteur SA
- Bharat Biotech
- Bavarian Nordic
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Human Rabies Vaccine (Vero Cell) Market Size (2021-2032)
- 2.2.2 Global Human Rabies Vaccine (Vero Cell) Sales (2021-2032)
- 2.2.3 Global Human Rabies Vaccine (Vero Cell) Market Average Price (2021-2032)
- 2.3 Human Rabies Vaccine (Vero Cell) by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 0.5ml
- 2.3.3 1ml
- 2.4 Human Rabies Vaccine (Vero Cell) by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital
- 2.4.3 Clinic
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Human Rabies Vaccine (Vero Cell) Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Human Rabies Vaccine (Vero Cell) Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Human Rabies Vaccine (Vero Cell) Revenue of Manufacturers (2021-2026)
- 3.4 Global Human Rabies Vaccine (Vero Cell) Average Price by Manufacturers (2021-2026)
- 3.5 Global Human Rabies Vaccine (Vero Cell) Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Human Rabies Vaccine (Vero Cell), Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Human Rabies Vaccine (Vero Cell), Product Type & Application
- 3.8 Global Manufacturers of Human Rabies Vaccine (Vero Cell), Established Date
- 3.9 Global Human Rabies Vaccine (Vero Cell) Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Changchun Zhuoyi Biology
- 4.1.1 Changchun Zhuoyi Biology Company Information
- 4.1.2 Changchun Zhuoyi Biology Business Overview
- 4.1.3 Changchun Zhuoyi Biology Human Rabies Vaccine (Vero Cell) Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Changchun Zhuoyi Biology Human Rabies Vaccine (Vero Cell) Product Portfolio
- 4.1.5 Changchun Zhuoyi Biology Recent Developments
- 4.2 Ningbo Rong'an
- 4.2.1 Ningbo Rong'an Company Information
- 4.2.2 Ningbo Rong'an Business Overview
- 4.2.3 Ningbo Rong'an Human Rabies Vaccine (Vero Cell) Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Ningbo Rong'an Human Rabies Vaccine (Vero Cell) Product Portfolio
- 4.2.5 Ningbo Rong'an Recent Developments
- 4.3 Liaoning Chengda
- 4.3.1 Liaoning Chengda Company Information
- 4.3.2 Liaoning Chengda Business Overview
- 4.3.3 Liaoning Chengda Human Rabies Vaccine (Vero Cell) Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Liaoning Chengda Human Rabies Vaccine (Vero Cell) Product Portfolio
- 4.3.5 Liaoning Chengda Recent Developments
- 4.4 Jilin Huikang Biopharmaceutical Co., Ltd.
- 4.4.1 Jilin Huikang Biopharmaceutical Co., Ltd. Company Information
- 4.4.2 Jilin Huikang Biopharmaceutical Co., Ltd. Business Overview
- 4.4.3 Jilin Huikang Biopharmaceutical Co., Ltd. Human Rabies Vaccine (Vero Cell) Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Jilin Huikang Biopharmaceutical Co., Ltd. Human Rabies Vaccine (Vero Cell) Product Portfolio
- 4.4.5 Jilin Huikang Biopharmaceutical Co., Ltd. Recent Developments
- 4.5 Hualan Bio-vaccine
- 4.5.1 Hualan Bio-vaccine Company Information
- 4.5.2 Hualan Bio-vaccine Business Overview
- 4.5.3 Hualan Bio-vaccine Human Rabies Vaccine (Vero Cell) Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Hualan Bio-vaccine Human Rabies Vaccine (Vero Cell) Product Portfolio
- 4.5.5 Hualan Bio-vaccine Recent Developments
- 4.6 Guangzhou Nuocheng
- 4.6.1 Guangzhou Nuocheng Company Information
- 4.6.2 Guangzhou Nuocheng Business Overview
- 4.6.3 Guangzhou Nuocheng Human Rabies Vaccine (Vero Cell) Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Guangzhou Nuocheng Human Rabies Vaccine (Vero Cell) Product Portfolio
- 4.6.5 Guangzhou Nuocheng Recent Developments
- 4.7 Dalian Yali Peak
- 4.7.1 Dalian Yali Peak Company Information
- 4.7.2 Dalian Yali Peak Business Overview
- 4.7.3 Dalian Yali Peak Human Rabies Vaccine (Vero Cell) Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Dalian Yali Peak Human Rabies Vaccine (Vero Cell) Product Portfolio
- 4.7.5 Dalian Yali Peak Recent Developments
- 4.8 Chengdu Kanghua Biology
- 4.8.1 Chengdu Kanghua Biology Company Information
- 4.8.2 Chengdu Kanghua Biology Business Overview
- 4.8.3 Chengdu Kanghua Biology Human Rabies Vaccine (Vero Cell) Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Chengdu Kanghua Biology Human Rabies Vaccine (Vero Cell) Product Portfolio
- 4.8.5 Chengdu Kanghua Biology Recent Developments
- 4.9 Serum Institute of India Pvt.
- 4.9.1 Serum Institute of India Pvt. Company Information
- 4.9.2 Serum Institute of India Pvt. Business Overview
- 4.9.3 Serum Institute of India Pvt. Human Rabies Vaccine (Vero Cell) Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Serum Institute of India Pvt. Human Rabies Vaccine (Vero Cell) Product Portfolio
- 4.9.5 Serum Institute of India Pvt. Recent Developments
- 4.10 Sanofi Pasteur SA
- 4.10.1 Sanofi Pasteur SA Company Information
- 4.10.2 Sanofi Pasteur SA Business Overview
- 4.10.3 Sanofi Pasteur SA Human Rabies Vaccine (Vero Cell) Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Sanofi Pasteur SA Human Rabies Vaccine (Vero Cell) Product Portfolio
- 4.10.5 Sanofi Pasteur SA Recent Developments
- 4.11 Bharat Biotech
- 4.11.1 Bharat Biotech Company Information
- 4.11.2 Bharat Biotech Business Overview
- 4.11.3 Bharat Biotech Human Rabies Vaccine (Vero Cell) Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Bharat Biotech Human Rabies Vaccine (Vero Cell) Product Portfolio
- 4.11.5 Bharat Biotech Recent Developments
- 4.12 Bavarian Nordic
- 4.12.1 Bavarian Nordic Company Information
- 4.12.2 Bavarian Nordic Business Overview
- 4.12.3 Bavarian Nordic Human Rabies Vaccine (Vero Cell) Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Bavarian Nordic Human Rabies Vaccine (Vero Cell) Product Portfolio
- 4.12.5 Bavarian Nordic Recent Developments
5 Global Human Rabies Vaccine (Vero Cell) Market Scenario by Region
- 5.1 Global Human Rabies Vaccine (Vero Cell) Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Human Rabies Vaccine (Vero Cell) Sales by Region: 2021-2032
- 5.2.1 Global Human Rabies Vaccine (Vero Cell) Sales by Region: 2021-2026
- 5.2.2 Global Human Rabies Vaccine (Vero Cell) Sales by Region: 2027-2032
- 5.3 Global Human Rabies Vaccine (Vero Cell) Revenue by Region: 2021-2032
- 5.3.1 Global Human Rabies Vaccine (Vero Cell) Revenue by Region: 2021-2026
- 5.3.2 Global Human Rabies Vaccine (Vero Cell) Revenue by Region: 2027-2032
- 5.4 North America Human Rabies Vaccine (Vero Cell) Market Facts & Figures by Country
- 5.4.1 North America Human Rabies Vaccine (Vero Cell) Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Human Rabies Vaccine (Vero Cell) Sales by Country (2021-2032)
- 5.4.3 North America Human Rabies Vaccine (Vero Cell) Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Human Rabies Vaccine (Vero Cell) Market Facts & Figures by Country
- 5.5.1 Europe Human Rabies Vaccine (Vero Cell) Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Human Rabies Vaccine (Vero Cell) Sales by Country (2021-2032)
- 5.5.3 Europe Human Rabies Vaccine (Vero Cell) Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Human Rabies Vaccine (Vero Cell) Market Facts & Figures by Country
- 5.6.1 Asia Pacific Human Rabies Vaccine (Vero Cell) Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Human Rabies Vaccine (Vero Cell) Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Human Rabies Vaccine (Vero Cell) Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Human Rabies Vaccine (Vero Cell) Market Facts & Figures by Country
- 5.7.1 South America Human Rabies Vaccine (Vero Cell) Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Human Rabies Vaccine (Vero Cell) Sales by Country (2021-2032)
- 5.7.3 South America Human Rabies Vaccine (Vero Cell) Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Human Rabies Vaccine (Vero Cell) Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Human Rabies Vaccine (Vero Cell) Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Human Rabies Vaccine (Vero Cell) Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Human Rabies Vaccine (Vero Cell) Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Human Rabies Vaccine (Vero Cell) Sales by Type (2021-2032)
- 6.1.1 Global Human Rabies Vaccine (Vero Cell) Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Human Rabies Vaccine (Vero Cell) Sales Market Share by Type (2021-2032)
- 6.2 Global Human Rabies Vaccine (Vero Cell) Revenue by Type (2021-2032)
- 6.2.1 Global Human Rabies Vaccine (Vero Cell) Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Human Rabies Vaccine (Vero Cell) Revenue Market Share by Type (2021-2032)
- 6.3 Global Human Rabies Vaccine (Vero Cell) Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Human Rabies Vaccine (Vero Cell) Sales by Application (2021-2032)
- 7.1.1 Global Human Rabies Vaccine (Vero Cell) Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Human Rabies Vaccine (Vero Cell) Sales Market Share by Application (2021-2032)
- 7.2 Global Human Rabies Vaccine (Vero Cell) Revenue by Application (2021-2032)
- 7.2.1 Global Human Rabies Vaccine (Vero Cell) Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Human Rabies Vaccine (Vero Cell) Revenue Market Share by Application (2021-2032)
- 7.3 Global Human Rabies Vaccine (Vero Cell) Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Human Rabies Vaccine (Vero Cell) Value Chain Analysis
- 8.1.1 Human Rabies Vaccine (Vero Cell) Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Human Rabies Vaccine (Vero Cell) Production Mode & Process
- 8.2 Human Rabies Vaccine (Vero Cell) Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Human Rabies Vaccine (Vero Cell) Distributors
- 8.2.3 Human Rabies Vaccine (Vero Cell) Customers
9 Global Human Rabies Vaccine (Vero Cell) Analyzing Market Dynamics
- 9.1 Human Rabies Vaccine (Vero Cell) Industry Trends
- 9.2 Human Rabies Vaccine (Vero Cell) Industry Drivers
- 9.3 Human Rabies Vaccine (Vero Cell) Industry Opportunities and Challenges
- 9.4 Human Rabies Vaccine (Vero Cell) Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst